Lyme Disease Vaccine Shows Promising Trial Results
A recent development in global healthcare has brought attention to Lyme disease, as pharmaceutical companies Pfizer and Valneva announced that their experimental vaccine demonstrated over 70% efficacy in late-stage clinical trials. This progress offers hope in combating a disease that is increasingly reported across multiple regions. About Lyme Disease Lyme disease, also known as Lyme borreliosis, is a bacterial infection caused by “Borrelia burgdorferi”. It affects multiple systems in the body, including the skin, joints, heart, and nervous system. The disease was first identified in 1976 in Lyme, Connecticut, United States , from which it derives its name. It is most commonly found in North America, Europe , and parts of Asia . Transmission and Spread Lyme disease is transmitted to humans through the bite of infected deer ticks, also known as black-legged ticks. These ticks are typically found in grassy, wooded, and bushy environments and can attach to the human body without im...
.png)
